As of 28 Aug 2026, Samrat Pharmachem Ltd share price is ₹245.60. The stock opened at ₹245.60 and had closed at ₹243.15 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹190.00 and a high of ₹333.00. In terms of performance, Samrat Pharmachem Ltd share price has increased by 21.31% over the past six months and has decreased by 24.42% over the last year.
Samrat Pharma Charts
Samrat Pharmachem Ltd Overview
About Samrat Pharma
Samrat Pharmachem is principal activities are manufacturing and selling chemicals. The shares of the Company are listed on stock exchanges in India.
Samrat Pharmachem Ltd Historical Performance
Samrat Pharmachem Ltd Fundamental Analysis
Samrat Pharmachem Ltd Financials
| Indicator | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 |
|---|---|---|---|---|---|
| Revenue | 80.75 | 71.46 | 63.83 | 78.92 | 76.34 |
| EBITDA | 1.89 | -1.54 | -0.25 | -0.31 | 0.82 |
| Net Profit | 0.88 | -2.04 | -0.46 | -0.59 | -0.23 |
| EPS | 2.84 | -6.59 | -1.49 | -1.90 | -0.74 |
Samrat Pharmachem Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 51.16 |
| MACD | -0.99 |
| 20-Day SMA | 242.10 |
Samrat Pharmachem Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Samrat Pharmachem Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,913.30+0.73% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,060.00+0.39% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,999.00+2.23% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Samrat Pharmachem Ltd today is ₹245.60 on NSE and ₹245.60 on BSE.
- The 52-week high of Samrat Pharmachem Ltd is ₹333.00, while the 52-week low is ₹190.00.
- The current market capitalisation of Samrat Pharmachem Ltd is approximately ₹76 crore.
- The P/E (Price-to-Earnings) ratio of Samrat Pharmachem Ltd is -34.40. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Samrat Pharmachem Ltd is 1.11. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Samrat Pharmachem Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Samrat Pharmachem Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Samrat Pharmachem Ltd has delivered a return of approximately -39.37%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Samrat Pharmachem Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 49.09% promoters, 3.24% FIIs, 0.00% DIIs, and 41.51% public shareholders.
